Dell Faulkingham, CCO at Akebia Therapeutics, Inc. (AKBA), sold 12,852 shares at $11.58 ($149K) on 2020-06-01, disclosed to the SEC on 2020-06-02.
Open-market sale of $149k AKBA by CCO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.58 | 6,426 | $74K | 50.0% |
| 2 | $11.58 | 6,426 | $74K | 50.0% |
| Total | $11.58 avg | 12,852 | $149K | 100% |
| Filing → |
| AKBA | SELL | 2021-03-02 | $23K | — | Filing → |